MNPR Monopar Therapeutics Inc.

Fundamentals / CIK 0001645469 / USD

Monopar Therapeutics Inc. reported $0 in revenue and a net loss of $20.60M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MNPR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$15.48MFY 2016 Revenue: $0FY 2016 Net Income: -$1.19M2016FY 2017 Revenue: $0FY 2017 Net Income: -$16.55M2017FY 2018 Revenue: $0FY 2018 Net Income: -$3.23M2018FY 2019 Revenue: $0FY 2019 Net Income: -$4.22M2019FY 2020 Net Income: -$6.30M2020FY 2021 Net Income: -$9.10M2021FY 2022 Net Income: -$10.52M2022FY 2023 Net Income: -$8.40M2023FY 2024 Revenue: $0FY 2024 Net Income: -$15.59M2024FY 2025 Revenue: $0FY 2025 Net Income: -$13.72M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 -- -- -- -- $0 $0 $0 $0
Research & Development $9.90M $13.01M $5.60M $7.59M $6.49M $4.07M $1.97M $1.77M $935K $280K
Total Operating Expenses $16.70M $16.16M $8.83M $10.54M $9.13M $6.51M $4.32M $3.33M $16.60M $1.19M
Operating Income -$16.70M -$16.16M -$8.83M -$10.54M -$9.13M -$6.51M -$4.32M -$3.33M -$16.60M -$1.19M
Interest Income $2.99M $404K $429K -- -- -- -- -- -- --
Income Before Tax -$13.72M -$15.59M -$8.40M -- -- -- -- -$3.30M -$16.55M --
Income Tax Expense $800 $800 $800 $800 $0 $18K $0 -$71K -$3.6K $800
Net Income -$13.72M -$15.59M -$8.40M -$10.52M -$9.10M -$6.30M -$4.22M -$3.23M -$16.55M -$1.19M
Basic EPS -$1.85 -$4.11 -$3.04 -$4.15 -$3.65 -$2.90 -$2.25 -$1.75 -$9.45 --
Diluted EPS -- -- -- -- -$3.65 -$2.90 -$2.25 -$1.75 -$9.45 --
Basic Shares Outstanding 7.4M 3.8M 2.8M 2.5M 2.5M 2.2M 1.9M 1.9M 1.8M --
Diluted Shares Outstanding -- -- -- -- 2.5M 2.2M 1.9M 1.9M 1.8M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 -- -- -- -- --
Research & Development $4.44M $4.77M $3.49M $3.94M $2.59M $1.73M $1.64M $9.92M
Total Operating Expenses $7.47M $6.64M $5.23M $6.16M $4.09M $3.23M $3.22M $11.07M
Operating Income -$7.47M -$6.64M -$5.23M -$6.16M -$4.09M -$3.23M -$3.22M -$11.07M
Interest Income $1.27M $1.30M $1.33M $954K $655K $781K $597K $149K
Net Income -$6.20M -$5.31M -$3.89M -$5.20M -$3.44M -$2.45M -$2.62M -$10.93M
Basic EPS -$0.72 -$0.62 -$0.46 -- -$0.48 -$0.35 -$0.38 --
Basic Shares Outstanding 8.6M 8.5M 8.5M -- 7.1M 7.0M 7.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $61.83M $45.82M $7.27M $8.19M $20.30M $16.74M $13.21M $6.89M $8.98M $2.07M
Short-Term Investments $60.88M $45.53M $6.54M $12.18M -- -- -- -- -- --
Cash & Short-Term Investments $122.7M $91.35M $13.81M $12.18M $20.01M $16.74M $13.21M $6.89M $8.98M $2.07M
Other Current Assets $64K $79K $66K $46K $218K $63K $16K -- -- --
Total Current Assets $140.5M $60.29M $7.33M $13.17M $20.52M $16.80M $13.23M $7.25M $9.13M $2.10M
Other Non-Current Assets -- -- -- -- $0 $69K $122K $66K -- --
Total Non-Current Assets $255K $0 $13K $61K $0 $69K $122K $66K $800K $800K
Total Assets $140.7M $60.29M $7.35M $13.23M $20.52M $16.87M $13.35M $7.32M $9.93M $2.90M
Total Current Liabilities $2.74M $5.25M $1.76M $3.13M $1.58M $1.18M $724K $400K $312K $65K
Total Non-Current Liabilities $155K $0 $0 $8.4K $0 $0 $0 $0 $0 $0
Total Liabilities $2.89M $5.25M $1.76M $3.14M $1.58M $1.18M $724K $400K $312K $65K
Total Debt (incl. Leases) $245K -- $8.4K $57K -- -- -- -- -- --
Common Stock $6.7K $6.1K $3.0K $13K $13K $11K $11K $9.3K $9.3K $0
Retained Earnings -$89.51M -$75.79M -$60.21M -$51.80M -$41.29M -$32.19M -$25.88M -$21.66M -$18.43M -$1.87M
Accumulated Other Comp. Income $131K $36K -$14K $8.9K -$3.2K -$7.9K -$11K -$2.4K $0 --
Total Stockholders' Equity $137.8M $55.04M $5.59M $10.09M $18.94M $15.69M $12.63M $6.92M $9.62M $2.83M
Total Equity $137.8M $55.04M $5.59M $10.09M $18.94M $15.69M $12.63M $6.92M $9.62M $2.83M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $52.63M $52.76M $52.54M $61.83M $127.7M $39.50M $39.71M $45.82M
Short-Term Investments $52.49M $52.61M $52.37M $60.88M $127.5M $39.33M $39.51M $45.53M
Cash & Short-Term Investments $105.1M $105.4M $104.9M $122.7M $255.2M $78.83M $79.23M $91.35M
Other Current Assets $435K $465K $251K $64K $415K $497K $524K $79K
Total Current Assets $129.9M $134.8M $137.7M $140.5M $144.1M $53.75M $55.08M $60.29M
Total Non-Current Assets $367K $215K $240K $255K $107K $118K $9.1K $0
Total Assets $130.2M $135.0M $138.0M $140.7M $144.2M $53.87M $55.09M $60.29M
Total Current Liabilities $2.98M $4.02M $2.46M $2.74M $2.57M $1.58M -- $5.25M
Total Non-Current Liabilities $200K $108K $132K $155K $71K $80K -- $0
Total Liabilities $3.18M $4.12M $2.59M $2.89M $2.64M $1.66M $1.49M $5.25M
Total Debt (incl. Leases) $357K $206K $230K $245K $102K $114K $8.3K --
Common Stock $6.8K $6.7K $6.7K $6.7K $6.7K $6.1K $6.1K $6.1K
Retained Earnings -$104.9M -$98.72M -$93.40M -$89.51M -$84.31M -$80.87M -$78.42M -$75.79M
Accumulated Other Comp. Income $95K $91K $99K $131K $12K $78K -$22K $36K
Total Stockholders' Equity $127.1M $130.9M $135.4M $137.8M $141.6M $52.20M $53.59M $55.04M
Total Equity $127.1M $130.9M $135.4M $137.8M $141.6M $52.20M $53.59M $55.04M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$13.72M -$15.59M -$8.40M -$10.52M -$9.10M -$6.30M -$4.22M -$3.23M -$16.55M -$1.19M
Stock-Based Compensation $4.84M $1.14M $1.90M $1.64M $1.47M $1.32M $1.01M $529K $305K $0
Operating Cash Flow -$12.20M -$6.40M -$7.86M -$7.23M -$7.32M -$4.66M -$3.02M -$2.68M -$2.63M -$1.19M
Investing Cash Flow -$63.45M -$14.34M $4.93M -$4.92M $0 -- -- -- -- --
Common Stock Issued $0 $4.20M $2.07M $109K -- $8.18M $0 $0 $4.71M $0
Share Repurchases -$35.00M $0 -- -- -- -- -- -- -- --
Financing Cash Flow $91.57M $59.29M $2.03M $33K $10.88M $8.18M $9.35M -$206K $9.54M $1.26M
Net Change in Cash $16.02M $38.55M -$920K -$12.12M $3.57M $3.52M $6.32M -$2.89M $6.91M $68K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.20M -$5.31M -$3.89M -$5.20M -$3.44M -$2.45M -$2.62M -$10.93M
Stock-Based Compensation $2.04M $1.43M $1.69M $1.10M $1.10M $1.28M $1.36M $279K
Operating Cash Flow -$6.17M -$3.25M -$3.47M -$3.06M -$2.41M -$1.08M -$5.66M -$2.00M
Investing Cash Flow $5.46M $4.12M -$5.58M -$62.19M -$2.13M $1.19M -$326K -$14.34M
Common Stock Issued -- -- -- $0 $0 $0 $0 $1.01M
Financing Cash Flow $586K -$647K -$200K -$699K $92.71M -$317K -$116K $56.14M
Net Change in Cash -$123K $214K -$9.29M -$65.84M $88.18M -$209K -$6.10M $39.80M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -10.0% -28.3% -150.4% -104.2% -48.1% -40.2% -33.5% -46.7% -172.1% -41.9%
Return on Assets (ROA) -9.7% -25.9% -114.4% -79.5% -44.4% -37.4% -31.6% -44.1% -166.7% -40.9%
Current Ratio 51.35x 11.47x 4.17x 4.21x 12.98x 14.28x 18.27x 18.15x 29.28x 32.48x
Quick Ratio 44.86x 17.39x 7.86x 3.89x 12.66x 14.22x 18.25x 17.25x 28.80x 32.13x
Debt to Equity 0.00x -- 0.00x 0.01x -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -16.2% -13.6% -11.1% -10.0% -13.7% -33.2% -30.9% -28.3%
Return on Assets (ROA) -15.8% -13.2% -10.9% -9.7% -13.5% -32.1% -30.1% -25.9%
Current Ratio 43.55x 33.56x 56.04x 51.35x 56.10x 33.94x -- 11.47x
Quick Ratio 35.25x 26.24x 42.69x 44.86x 99.35x 49.78x -- 17.39x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x --
Source: SEC EDGAR CompanyFacts (CIK 0001645469) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:36 UTC · Open in terminal